0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Application of DNA sequences in anti-counterfeiting: Current progress and challenges

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Graphical abstract

          Abstract

          Counterfeiting has never been more challenging than during the COVID-19 pandemic as counterfeit test kits and therapeutics have been discovered in the market. Current anti-counterfeiting labels have weaknesses: they can either be duplicated easily, are expensive or ill-suited for the existing complex supply chains. While RFID tags provide for an excellent alternative to current anti-counterfeiting methods, they can prove to be expensive and other routes involving nanomaterials can be difficult to encrypt. A DNA based anticounterfeiting system has significant advantages such as relative ease of synthesis and vast data storage abilities, along with great potential in encryption. Although DNA is equipped with such beneficial properties, major challenges that limit its real-world anti-counterfeiting applications include protection in harsh environments, rapid inexpensive sequence determination, and its attachment to products. This review elaborates the current progress of DNA based anti-counterfeiting systems and identifies technological gaps that need to be filled for its practical application. Progress made on addressing the primary challenges associated with the use of DNA, and potential solutions are discussed.

          Related collections

          Most cited references82

          • Record: found
          • Abstract: not found
          • Article: not found

          Advanced carbon electrode materials for molecular electrochemistry.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Electrochemical DNA sensors.

            Electrochemistry-based sensors offer sensitivity, selectivity and low cost for the detection of selected DNA sequences or mutated genes associated with human disease. DNA-based electrochemical sensors exploit a range of different chemistries, but all take advantage of nanoscale interactions between the target in solution, the recognition layer and a solid electrode surface. Numerous approaches to electrochemical detection have been developed, including direct electrochemistry of DNA, electrochemistry at polymer-modified electrodes, electrochemistry of DNA-specific redox reporters, electrochemical amplifications with nanoparticles, and electrochemical devices based on DNA-mediated charge transport chemistry.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.

              Poor-quality antimalarial drugs lead to drug resistance and inadequate treatment, which pose an urgent threat to vulnerable populations and jeopardise progress and investments in combating malaria. Emergence of artemisinin resistance or tolerance in Plasmodium falciparum on the Thailand-Cambodia border makes protection of the effectiveness of the drug supply imperative. We reviewed published and unpublished studies reporting chemical analyses and assessments of packaging of antimalarial drugs. Of 1437 samples of drugs in five classes from seven countries in southeast Asia, 497 (35%) failed chemical analysis, 423 (46%) of 919 failed packaging analysis, and 450 (36%) of 1260 were classified as falsified. In 21 surveys of drugs from six classes from 21 countries in sub-Saharan Africa, 796 (35%) of 2297 failed chemical analysis, 28 (36%) of 77 failed packaging analysis, and 79 (20%) of 389 were classified as falsified. Data were insufficient to identify the frequency of substandard (products resulting from poor manufacturing) antimalarial drugs, and packaging analysis data were scarce. Concurrent interventions and a multifaceted approach are needed to define and eliminate criminal production, distribution, and poor manufacturing of antimalarial drugs. Empowering of national medicine regulatory authorities to protect the global drug supply is more important than ever. Copyright © 2012 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Int J Pharm
                Int J Pharm
                International Journal of Pharmaceutics
                Elsevier B.V.
                0378-5173
                1873-3476
                9 April 2021
                1 June 2021
                9 April 2021
                : 602
                : 120580
                Affiliations
                [a ]Department of Biosystems and Agriculture Engineering, Michigan State University, East Lansing, MI, United States
                [b ]Department of Electrical and Computer Engineering, Michigan State University, East Lansing, MI, United States
                [c ]Global Alliance for Rapid Diagnostics, Michigan State University, East Lansing, MI, United States
                Author notes
                [* ]Corresponding author at: 512, South Shaw Lane, Department of Biosystems and Agriculture Engineering, Michigan State University, East Lansing, MI, United States.
                Article
                S0378-5173(21)00385-9 120580
                10.1016/j.ijpharm.2021.120580
                9579332
                33839229
                ae367b08-7b3e-4a7b-8ad6-e0a776fc86be
                © 2021 Elsevier B.V. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 31 December 2020
                : 25 March 2021
                : 3 April 2021
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                Pharmacology & Pharmaceutical medicine

                Comments

                Comment on this article